Skandinaviska Enskilda Banken (SEB)
IRWD icon

Skandinaviska Enskilda Banken (SEB)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-98,300
Closed -$1.12M – 868
2023
Q4 		$1.12M Sell
98,300
-51,600
-34% -$510K 0.01% 682
2023
Q3 		$1.44M Sell
149,900
-70,900
-32% -$695K 0.01% 613
2023
Q2 		$2.35M Buy
220,800
+158,200
+253% +$1.7M 0.02% 527
2023
Q1 		$659K Buy
+62,600
New +$701K ﹤0.01% 743
2022
Q3 		– Sell
-135,500
Closed -$1.56M – 970
2022
Q2 		$1.56M Sell
135,500
-107,300
-44% -$1.26M 0.01% 632
2022
Q1 		$3.05M Sell
242,800
-171,700
-41% -$1.97M 0.02% 520
2021
Q4 		$4.85M Sell
414,500
-1,805,900
-81% -$22.2M 0.03% 429
2021
Q3 		$29M Buy
2,220,400
+2,005,800
+935% +$25.9M 0.16% 140
2021
Q2 		$2.76M Sell
214,600
-1,000
-0.5% -$11.4K 0.02% 580
2021
Q1 		$2.41M Sell
215,600
-467,300
-68% -$4.94M 0.02% 605
2020
Q4 		$7.78M Buy
682,900
+281,300
+70% +$3.08M 0.05% 291
2020
Q3 		$3.61M Buy
401,600
+192,400
+92% +$1.91M 0.03% 407
2020
Q2 		$2.16M Buy
209,200
+167,300
+399% +$1.71M 0.02% 532
2020
Q1 		$423K Sell
41,900
-144,300
-77% -$1.7M ﹤0.01% 762
2019
Q4 		$2.48M Buy
+186,200
New +$2.05M 0.02% 500
2019
Q1 		– Sell
-276,292
Closed -$2.4M – 723
2018
Q4 		$2.4M Buy
+276,292
New +$3.17M 0.02% 427

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IRWD Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 98,300 shares — an estimated $1.12M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IRWD in Q4 2018 and held it in 16 quarters. The position peaked at $29M in Q3 2021. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 98,300 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $1.12M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 16 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Ironwood Pharmaceuticals position peaked at $29M in Q3 2021.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.